3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) saw a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 2,443,617 shares, a growth of 345.1% from the May 14th total of 549,065 shares. Based on an average trading volume of 12,127 shares, the short-interest ratio is presently 201.5 days.
3SBio Price Performance
Shares of TRSBF opened at $2.20 on Friday. 3SBio has a one year low of $2.00 and a one year high of $4.74. The business has a fifty day moving average of $2.74 and a 200 day moving average of $3.01.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
Featured Stories
- Five stocks we like better than 3SBio
- Why Oracle’s 10% Drop May Be Telling the Wrong Story
- Build On a Strong Earnings Season With These 3 ETFs
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
